Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

In June 2017, a diverse group of experts in Alzheimer’s disease convened to discuss how to accelerate getting new drugs to patients to both prevent and treat the disease. Participants concluded that we need a more robust, diversified drug development pipeline. Strategic policy measures can help keep new Alzheimer’s disease Read & Research Alzheimer’s More

Leave a Reply